Intra-Cellular Therapies Highlights Lumateperone Bipolar Depression Data Presentations at the 2022 International Society for Bipolar Disorders (ISBD) Experience

Source: Nasdaq GlobeNewswire / 13 Jun 2022 07:00:01   America/Chicago